|
Incidence of infections in clinical trials of treatments for relapsed/refractory multiple myeloma: Systematic review and meta-analysis. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
Research Funding - Regeneron |
Travel, Accommodations, Expenses - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Novartis; Regeneron |